17/04/2026
Haemophilia is a congenital blood-clotting disorder in which certain clotting factors are missing or non-functional. As a result, the blood can no longer clot properly, leading to excessively prolonged or severe bleeding – even following minor injuries or spontaneously within the body.
But what does this mean for surgical procedures in patients with ? How can bleeding be reliably controlled when natural clotting is impaired? This is precisely where targeted, locally effective is crucial.
HaemoCer PLUS can be used in this context as a supportive measure in the operating theatre. The plant-based haemostatic powder has an extremely high water absorption capacity, which accelerates natural blood clotting without chemical or pharmaceutical interaction. This leads to an accumulation of fibrin, thrombin and red blood cells at the source of the bleeding, thereby stopping the bleeding. In this way, HaemoCer PLUS makes a valuable contribution to during surgery in patients.
